Case Reports and Reviews: Open Access

Drug-Induced Hepatitis Following Albendazole Use: A Case Report and Literature Review

Fedaa Housen, Maryam Alkhatry, Haris Ejaz, Bashar Almasri, and Qonith Gibrata

Article DOI: https://doi.org/10.70620/CRROA/v7i1/154

Abstract

Albendazole is a broad-spectrum anthelmintic drug generally regarded as safe. Rarely, it may cause acute toxic hepatitis. We report a case of severe hepatotoxicity following albendazole use in a pediatric patient. Other causes of acute hepatitis were excluded, and the Roussel Uclaf Causality Assessment Method (RUCAM) score was 8, indicating a highly probable drug-induced liver injury.

Keywords: Albendazole; Drug-induced hepatitis; Hepatotoxicity; RUCAM; Anthelmintics.